Halil I. Ciftci
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 5%
- Synthesis and biological activity
- Click Chemistry and Applications
- Synthesis and Biological Evaluation
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
Papers in
-
- Synthesis and biological activity 18
-
- Cancer therapeutics and mechanisms 7
- Co-authors
- Mikako Fujita (45 shared papers)Masami Otsuka (43 shared papers)Mohamed O. Radwan (21 shared papers)Belgin Sever (27 shared papers)Mehlika Dilek Altıntop (7 shared papers)Ahmet Özdemır (6 shared papers)Hiroshi Tateishi (23 shared papers)Ryoko Koga (16 shared papers)
In The Last Decade
Halil I. Ciftci
50 papers receiving 946 citations
Peers
Comparison fields: 5 of 80
- Toxicology 184
- Organic Chemistry 488
- Geriatrics and Gerontology 38
- Virology 45
- Physiology 28
Countries citing papers authored by Halil I. Ciftci
This map shows the geographic impact of Halil I. Ciftci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil I. Ciftci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil I. Ciftci more than expected).
Fields of papers citing papers by Halil I. Ciftci
This network shows the impact of papers produced by Halil I. Ciftci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil I. Ciftci. The network helps show where Halil I. Ciftci may publish in the future.
Co-authors
The 25 scholars most cited alongside Halil I. Ciftci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 98 | |
| 2 | 2015 | 84 | |
| 3 | 2017 | 56 | |
| 4 | 2022 | 53 | |
| 5 | 2020 | 45 | |
| 6 | 2018 | 41 | |
| 7 | 2019 | 37 | |
| 8 | 2017 | 36 | |
| 9 | 2019 | 31 | |
| 10 | 2019 | 31 | |
| 11 | 2021 | 28 | |
| 12 | 2017 | 28 | |
| 13 | 2021 | 26 | |
| 14 | 2019 | 25 | |
| 15 | 2019 | 25 | |
| 16 | 2021 | 25 | |
| 17 | 2020 | 21 | |
| 18 | 2024 | 20 | |
| 19 | 2015 | 19 | |
| 20 | 2017 | 18 |
About Halil I. Ciftci
Halil I. Ciftci is a scholar working on Organic Chemistry, Molecular Biology, Toxicology, Virology and Infectious Diseases, having authored 51 papers that have together received 953 indexed citations. Recurring topics across this work include Synthesis and biological activity (18 papers), Bioactive Compounds and Antitumor Agents (10 papers), Cancer therapeutics and mechanisms (7 papers), HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Fungal Plant Pathogen Control (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Toxicology (184 citations), Organic Chemistry (488 citations), Geriatrics and Gerontology (38 citations), Virology (45 citations) and Physiology (28 citations). Halil I. Ciftci has collaborated with scholars based in Japan, Türkiye and Egypt. Frequent co-authors include Mikako Fujita, Masami Otsuka, Mohamed O. Radwan, Belgin Sever, Mehlika Dilek Altıntop, Ahmet Özdemır, Hiroshi Tateishi, Ryoko Koga, Amaç Fatih Tuyun and Taha F. S. Ali. Their work appears in journals such as Molecules, Pharmaceuticals, International Journal of Molecular Sciences, Archiv der Pharmazie and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.